Trypan-blue exclusion cell viability assay for MCL-5 cells treated with andrographolide for 24 hours.Mean % Non- viable cells3.006.04E+055.94E+055.61E+054.22E+053.26E+05Mean cell concentration (cells/ml)5.84E+0516*96 93.6291.8493.8881.0311.2577.0972.5768.7562.7846.9646.6343.2133.5733.5934.17% Viable cells96.8596.713.096.38 8.16ZV9 18.9722.7522.9127.4331.25 ZZ'Li 53.04 j53.3756.7966.4366.4165.83% Non- viable cells3.153.296.48E+055.88E+056.13E+056.13E+056.33E+055.83E+055.68E+055.65E+055.60E+055.58E+054.53E+054.08E+054.05E+053.50E+053.28E+053.00E+05Cell cone (cells/ml)5.55E+056.08E+05259235245245253233 LZZ 226224223 1--H0 0mvo <NVO o'"i' cn 120iTotal222243oo 1i 20 l--H 48 53 52 62 70 83 96 87 92 93 87 79Dead (blue)t- - 00251220225230205180VO1--H T--1o l o00 76 70 47 44Alive215235o1--H 30 50 7006DoseoCopy I 277oor~~-CN96.8094.4679.4759.73 oH(c) 30.143.205.5420.5340.2759.9069.865.73E+055.15E+054.63E+054.29E+052.78E+052.40E+0597.4696.5897.4096.4194.2093.75 cnuSOS 79.2380.2278.9556.6564.9757.5841.67 ooSO(c) 37.9634.5532.6123.262.543.422.603.595.806.254.5720.7719.7821.0543.3535.03 zvzp 58.3359.3262.0465.4567.3976.74i 5.90E+055.85E+055.78E+055.58E+055.18E+054.80E+055.48E+054.58E+054.55E+054.75E+054.33E+054.43E+054.13E+052.70E+052.95E+052.70E+052.75E+052.30E+052.15E+05236234 i--hcnCN 223207 CNOsr-H 219 cn00r-HCN00r-HoOsT--Hcnr --Hr-r-r-Hsot-H 108 oot-H00oT--Ho^H 92 86so oo so 00 (N1 I CNr-H o1--H 38 36 40 75 62 70 63 70 67 72 6299230226225215 mOsT1--Ho 00 T--1 209145 SON"H^ 15098 r-Ht-H 95 45 48r-HN" 38 30 20DMSO Or-H 30 50 7006Copy 1Table A14. Trypan-blue exclusion cell viability assay for V-79 cells treated with andrographolide for 24 hours.Mean % Viable cells93.3193.0392.9285.5561.7538.9024.24Mean % Non- viable cells6.696.97 00o14.4538.2561.1075.76Mean cell concentration (cells/ml)3.63E+053.23E+052.93E+052.03E+052.00E+057.50E+044.83E+04% Viable cells92.2594.1693.5392.3193.5093.2893.3393.6991.74 or-Hoooo 84.6283.9560.7657.8366.67 oooN- 38.4638.2421.05% Non- viable cells7.75 #'3-00u sLY9 7.696.506.72| 6.676.318.2611.9015.3816.0539.2442.1733.3360.0061.5461.7678.95Cell cone (cells/ml)3.55E+053.85E+053.48E+053.25E+053.08E+053.35E+053.00E+052.78E+053.03E+052.10E+051.95E+052.03E+051.98E+052.08E+051.95E+057.50E+046.50E+048.50E+044.75E+04TotalCNr-H 154 Oscn1--Hocnr--Hcn(Nr-HT ient-HoCNr-Hr-H^ HCNr-H 84 78r-Hoo 79 83 78 30 26 34 ONDead (blue)^ H O n O n Or-H oo Os OO o o CNr^H cnr-H rHm 35 26 00r-H SOr-H CN r --HAlive r-Hm IT)r-HOcnr-HoCN^ HITSCNCN^#HN"O<<^Hr-H 7499 89 48 48 52 CNrH or-H cnrHDoseoDMSO Or-H 30 50 7006ooo<NMean Vo Viable cells74.3872.6155.0218.598.9216.18Mean % Non- viable cells25.6227.3944.9881.4100pr" Hov 83.82e for 48 hours.Mean cell concentration (cells/ml)8.93E+059.04E+056.28E+052.42E+051.39E+057.50E+0426.6725.00is treated with andrographolid% Viable cells76.2674.77 IVZL 72.0171.2874.5550.4556.1458.4722.0813.19 6fr'0S 7.325.5613.8916.1373.33 o(c)in% Non- viable cells23.7425.2327.8927.9928.7225.4549.5543.8641.5377.9286.8179.5192.6894.4486.1183.873.75E+046.00E+04"SuOvi>a%C/5C/5cdPS1>Cell cone (cells/ml)9.90E+058.03E+058.88E+059.20E+059.58E+058.35E+055.50E+057.13E+056.20E+051.93E+052.28E+053.05E+051.03E+051.35E+051.80E+057.75E+04in 24Total396 ^HCNm 355368383334222285248 77 OVCN CN 1 1r-H 54 72 1--Hcny-Ht-H00a>oc_o'35oX<u<L>Dead(blue)94 r-H0066 mor-Hor-H 85or-HH 125 mor-H09 79 97 38 m 62 26VO0 IB1Hm<a>IHAlive302240256265273249 CN^HoVOr ^ r-HCNr-H 25 cn m o inDoseoDMSO Or-H 30 50 70ooCNcnVOO ninCNOs(c)+Winovdr-CNinCNCNopi nCNopinr"o+WopooCNcn#'tCN00cnpcnooo+Woopinvovocncncnooo+WoinooOSpinCN00!>#VOvdcncncnooN-O+WmPONin VOo+WoovdN"CNOCNcnoONcn.5u-BCxOj.s*sa3aa(c)d3$aa(c)da ga;oH(c)oZJ (c) (c) > -M (c)da(c)j-oJ3 .. (c) v (c) >(c) T da(c) o (c) ^Q x 'vomCNCNVOcnooC"-CNcncnoo'toopCNinON00cnvoCNCNCNr-r"vomcncncnmo(c)(c)mopinN-vovdN-Oo(c)moo(c)cnVOr>pvdcncnpooCNOOinCNoo(c)cncncnoor-vovdn-oo(c)mopininoo(c)in(c)oCDcnpoomcnpcnvovo o(c)int^ >>(c)(c)(c)r-'-(c)SO(c)vo (c)(c) (c)SO (c)(c) (c)VO (c)vo (c)vo (c)VO (c)vo (c)vo (c)vocn CNcn (c)cn C"-CN 00CN (c)cn oo CNCN in 00ONCN00CN(c)cn cncn CNcn (c)cn CN oocn cnN" in'f CN'U-(c)cn (c)inCopy 1<NOO<Nft.<u4-1anCO*#*COo*0J3tJ-<Nu,PSa>T3'o&1osr-I>.9hiJ-(c)CM* PNi.Hs. (c)CM* p*PQs#wt/5oQ(NVOm OsOVcda> oiISo3oX&a3OU"os"MoHo>UwvcnpOahV(c)ceOQvom0> t-Hx V]cooo<NT3<UPS_oT3PS<a3oJS&&o*#PS3Ov#>.sPS1#&*sCOuoHSc0C31 PS <SS OS<<D1H-*McSoUOJ 400 400400400400oHu<<o&*M**2CN CN m or-HmS*OSo&A9m-MVHCN i n m c o t oTripolarOsr-H IT) 23 44 45k .OSmuoa 377378367333327CQ=La>C0oQoDMSO oH 30 50co coIT)CNCOPQ5! Qi Q!ooCNoO hosiTT<N0 siSS1feb1HQJ'OaHHU*#a(c)asoUoHsa.S d& 3V VJ4>wOQ>>nOs<u&<Da>cdoE ,<Ut-lX)ueda>Obai3EfI SS8 o oCO o otoT3 1>c3Oha>VhO,Scn a>*00*S .o 2o oT3& O > a>T3a>t>O o o2 VPSCO"3a>.SS ^3E <0<D fe;O, o r r oCO<SSa>3COa>O ha><u3oE,2CDa>3HedvhooosiooN'a>.3EsiO*w73aa3oUoH(c)U(c)a --e J3 o> Ua>VIoQCN00iriOs>>noo00vdoCOl>COo00CN00 COvdoooCOoooCOoooCOoooCOoooCOoooCOvouo oCNcoCNCN CNTi-ooCNt -o00CNvoOsCNf "Or^-CNCO00r">CNoCOoI/O oaC/3Table A23. Raw data on the incidence of aberrant mitosis in V-79 cells treated with andrographolide for 24 hours.oXN"<Na<on2'oXp.Iasotj"poHa73IoPSooOsOoOsooOV0000VOr-00CNO00CNCNCNOvcn ooOVO</)CnoQom<utfl CO<u o 4a T3op {i3*S o-w CO=1 <Do t3 (U fl <<-i coS *SSr:0) o<U ug>T3<uCOMOsi>.B.B"63aoT3<L>coPCL)*PpoopT3o.a<uPSp0CdcdT31#8HT3<WcnPVt spoop* P*Pa OVo #^HT-H VO oVO CN00 CNVO cncnoNppo>souA<yo O O o Hcn mPPowp 4501450045004500450045004500oHp-C-*Pr|ClouAwX5<UcnPVT3PON- r- 27 82 163240Normal4497449544934473441843374260srp.N--ucnOCoDMS0 o 30 50 7006(L)3O.P&5'O<wcnP<< P5 p<< a^ 2 ^ JaP w030>PPow'p-**oHpaouAw*04)cnP4>T3POUpaoPSVcnOO>>nooCNcn1--HO00(c)oov>oovr>oomN"in vo ooN"Ovrj-N-CNOvP"N"ocoCopy 10.69LOT 4.386Z'945004500 oom#h*(c)(c)lo#H"T-Hcn 93 197238446944074303426230 50 7006uoN-CMOJ38-ooT3t3a>&T3<Ucd$OSr-#>CMo<UPSoo"3ooa01 #8*#8H%Multi (c)(c)(c)orooro (c)(c)(c)(c)(c)(c)orooroorooro 0.200.20oro (c)(c) 0.20oro%Tetra(c)(c)(c)*oro 0.20oro (c)(c)(c)* 0.200.30oro 0.200.20 (c)h-(c)oro 0.800.900.70%Tri0.30oro 0.300.200.200.30oro (c)H-(c)oro 0.30 (c)r3-(c) 0.40 1.00 1.202.50%Bi2.40 (c)(c)1 4.603.202.503.60 (c)(c)2.805.90 (c)(c) (c)oo 6.000VZI 11.4016.50Total1000100010000001 10001000100010001000100010001000100010001000cnV#MAVMPw0f l* pfl1 3s(c) - l--H (c) (c) - l-H - r-H CMCMt--H in CN CMcnV-***f l73Sf lf lUH(c) CM r-H (c) CM m - CM CM CN oo OS r "Trinucleatesm - cn CM CN cn - r-H cn(c) CN 25Binucleates24 40 46 32 25 36 40 28 59 70 8509 CMHN "t-Hmsot-HMononucleates973957948965973958955 996 937923905933853863 r-H(c)oocn 5 O ^(5 3(c) (c) (c) (c)DMSODMSODMSODMSO (c)r-H(c)r-H(c)r-H(c) 30 30 30Copy I 2860.20 o(c) 0.200.300.20 ooo(c) 0.60 o"'t(c) 0.500.200.300.20 (c)(c)(c)op o(c)or-(c)oo 0.400.60oro 0.20 (c)m(c)(c)CN(c) 0.00oro (c)(c)(c)1.50 1.501.401.50 opon ooooom(c)(c)(c)(c)(c) 0.600.300.20o0 00 1 14.90 op13.5012.5013.009.008.509.205.00 (c)0 0#'sf 3.804.200001 100010001000100010001000100010001000100010001000<N r-"- CN c n CN oo vo in CN cn CN (c)o r- r j- "3 - v o t-H CN in CN (c) ^H (c)lO int-hint-HOY= ' A T" H 0 0 in vo c n CNi 128149 o^H 135125 om^H06 85 92 50 48 38 42lOo o 822837843859845895904894942943956956om 50 50 50 50 70 70 70 7006 06 06 06fl2sSa4>HI*Hns(r)aOHs<<a>-**93.